J. Reese

发表

Hematopoietic stem cell gene therapy: progress toward therapeutic targets

S. Gerson, S. Zielske, J. Vollweiler, 2003, Bone Marrow Transplantation.

Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells

H. Meyerson, M. de Lima, L. Metheny, 2014, Hematology & medical oncology.

Emerging therapeutic approaches for multipotent mesenchymal stromal cells

Z. Lee, H. Lazarus, P. Caimi, 2010, Current opinion in hematology.

MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure.

M. Sekiguchi, S. Gerson, C. Ballas, 2001, Journal of hematotherapy & stem cell research.

In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning.

S. Gerson, S. Zielske, J. Reese, 2003, The Journal of clinical investigation.

Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected

M. de Lima, E. Malek, Byung-Gyu Kim, 2019, Leukemia & lymphoma.

MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors.

S. Gerson, J. Reese, Justin C. Roth, 2015, Virus research.

Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism

Jeffrey A. Cohen, A. Bar-Or, S. Planchon, 2016, Stem cells translational medicine.

Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance.

J. Allay, S. Gerson, O. Koç, 1996, Seminars in oncology.

Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea.

J. Allay, S. Gerson, O. Koç, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice

S. Gerson, E. Allay, J. Reese, 2001, Oncogene.

Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer

S. Gerson, O. Koç, J. Reese, 1999, Cancer Gene Therapy.

Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients.

S. Gerson, J. Reese, B. M. Davis, 2003, Journal of hematotherapy & stem cell research.

Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients.

S. Gerson, J. Reese, Karen T. Lingas, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

S. Gerson, O. Koç, K. Lee, 1997, Cancer research.

Cell-Based Drug Development , Screening , and Toxicology Human Mesenchymal Stem Cells Impact Th 17 and Th 1 Responses Through a Prostaglandin E 2 and Myeloid-Dependent Mechanism

Jeffrey A. Cohen, A. Bar-Or, S. Planchon, 2016 .

Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.

S. Gerson, J. Reese, B. M. Davis, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma

R. Sékaly, R. Orentas, M. de Lima, 2020, Frontiers in Immunology.

Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase

N. Sedransk, S. Gerson, E. Allay, 1997, Oncogene.

Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo

S. Gerson, G. Ferrari, J. Reese, 2012, ISRN hematology.

Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction.

S. Gerson, O. Koç, J. Reese, 1999, Journal of hematotherapy & stem cell research.

Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment

Sukhmani Kaur, David Fletcher, Aaron Weinberg, 2016, Stem cells international.

Sequential single cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin’s lymphoma

M. de Lima, T. Hwang, P. Caimi, 2021, bioRxiv.

In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells

J. Kappes, D. Dimitrov, J. Berman, 2022, JCI insight.

Bone Marrow‐Derived Cells Exhibiting Lung Epithelial Cell Characteristics Are Enriched In Vivo Using Methylguanine DNA Methyltransferase‐Mediated Drug Resistance

S. Gerson, J. Reese, Justin C. Roth, 2008, Stem cells.

DNA repair in stem cell maintenance and conversion to cancer stem cells.

S. Gerson, J. Kenyon, J. Reese, 2006, Ernst Schering Foundation symposium proceedings.

Issues in Moving Gene Therapy Approaches to Early Clinical Trials

J. Grandis, S. Gerson, S. Thomas, 2014 .

The sialyl-glycolipid SSEA 4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features

F. Marincola, C. Hudis, M. Ceccarelli, 2015 .

Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)

N. Geller, N. Munshi, M. Pasquini, 2021, Blood.

A phase I study of MGMT-P140K transfected hematopoetic progenitor cells (HPC) combined with TMZ/O6BG dose escalation for newly diagnosed, MGMT unmethylated glioblastoma: Tolerance and evidence of survival benefit.

A. Sloan, C. Murphy, S. Gerson, 2019, Journal of Clinical Oncology.

Progressive Emergence of a Dominant Unit during Dual Unit Umbilical Cord Blood (UCB) Culture.

Min Liu, S. Gerson, J. Reese, 2005 .

A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis.

A. Caplan, H. Lazarus, S. Heltshe, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

1006. Preliminary Results of a Phase I Trial Using Retroviral Gene Transfer of G156A MGMT To Protect Hematopoiesis during BG and BCNU Therapy of Advanced Malignancies

S. Gerson, O. Koç, J. Reese, 2004 .

DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.

S. Gerson, O. Koç, J. Reese, 1999, Human gene therapy.

A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.

A. Otero-Piñeiro, J. Reese, A. Lightner, 2023, Inflammatory bowel diseases.

Repopulating defect of mismatch repair-deficient hematopoietic stem cells.

Lili Liu, S. Gerson, J. Reese, 2003, Blood.

A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow–Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn’s Disease

S. Steele, J. Reese, A. Lightner, 2023, Diseases of the colon and rectum.